A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.

PHASE3RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

July 31, 2027

Conditions
Congenital Pseudarthrosis of Tibia
Interventions
BIOLOGICAL

NVD003

Bone correction and grafting surgery

PROCEDURE

Iliac Crest Bone Graft

"Either a single-stage Grafting Surgery with internal fixation and cross-union or the 2-stage induced membrane Grafting Surgery approach, depending on the surgeon's own standard of care."

Trial Locations (1)

21117

RECRUITING

LifeBridge Health - International Center for Limb Lengthening, Baltimore

Sponsors
All Listed Sponsors
lead

Novadip Biosciences

INDUSTRY

NCT07112443 - A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia. | Biotech Hunter | Biotech Hunter